ArticleAnnals of clinical and translational neurology2024

A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis.

Pietro Iaffaldano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.